Stevanato Group announced today that the underwriters of its recently completed initial public offering purchased more than 1 million additional shares.
The option exercised by the underwriters saw the acquisition of an additional 1,018,280 ordinary Stevanato Group shares at $21 per share.
Get the full story at our sister site, Drug Delivery Business News.
